Digital Transformation

This evolution of healthcare involves using technology to improve diagnosis, treatments, monitor patients, enhance hospital operations and culture, and bolster consumer-focused care. This includes virtual reality tools, wearable devices, workflow software, health apps and other digital health tools.

Thumbnail

Healthcare workforce management company raises $200M

The funding comes at a time when the healthcare workforce is facing a major labor crunch.

CVS Health announces $10.6B acquisition of Oak Street Health

CVS Health announces $10.6B acquisition of Oak Street Health

The deal was expected to be announced after several stories leaked that the two companies were in talks.

Thumbnail

Justice Dept. takes down ransomware group targeting hospitals

The group targeted 1,500 victims in over 80 countries and received more than $100M since June 2021.

Thumbnail

Walgreens may sell $2B pharmacy automation business

The move comes as Walgreens is shoring up its business amid a period of big transactions in the healthcare space.

colon colorectal cancer CTC

Kroger launches colorectal clinical trial sites

Kroger’s latest move underscores how large companies in other industries are making their way into the healthcare space.

Thumbnail

CVS Health launches new virtual primary care service

CVS Health has launched its new virtual primary care offering with 24/7 on-demand care and scheduled mental health services.

Amazon launches $5 prescription services program

The medications included in the program treat more than 80 conditions.

Animal testing no longer required for all new drugs approved by FDA

The bill was first introduced by Sens. Rand Paul (R-KY) and Cory Booker (D-NJ) in the Senate, and it was approved unanimously.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.